FIELD: chemistry of organophosphorus compounds, medicine, pharmacy.
SUBSTANCE: invention relates to new compounds of the formula (1) 
showing affinity to one or more GABAB receptors and their pharmaceutically acceptable salts, solvates and stereoisomers but with exception for racemate of (3-amino-2-hydroxypropyl)-phosphinic acid. Invention provides increasing the therapeutic index value.
EFFECT: improved and valuable properties of compounds.
14 cl, 1 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW (AMINOPROPYL)METHYLPHOSPHINIC ACIDS | 2000 |
|
RU2267495C2 |
| (6S,9AS)-N-BENZYL-6-[(4-HYDROXYPHENYL)METHYL]-4,7-DIOXO-8-({6-[3-(PIPERAZIN-1-YL)AZETHYDIN-1-YL]PYRIDINE-2-YL}METHYL)-2-(PROP-2-EN-1-YL)-OCTAHYDRO-1H-PYRASINO[2,1-C][1,2,4]TRIAZINE-1-CARBOXAMIDE COMPOUND | 2014 |
|
RU2669805C2 |
| PHENICOL ANTIBACTERIAL AGENTS | 2013 |
|
RU2593204C2 |
| ADAMANTYL DERIVATIVES USEFUL FOR TREATMENT OF JNK-MEDIATED DISORDER | 2012 |
|
RU2626890C2 |
| VLA-4 INHIBITORS | 2001 |
|
RU2290403C2 |
| DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES | 2001 |
|
RU2265011C2 |
| TLR7 AGONISTS | 2019 |
|
RU2817014C2 |
| SYNERGETIC TREATMENT OF PARKINSONISM | 1995 |
|
RU2176145C2 |
| SPIRO-FUSED PIPERIDINE DERIVATIVES FOR APPLICATION AS INHIBITORS OF EXTERNAL MEDULLAR LAYER POTASSIUM CHANNEL | 2013 |
|
RU2642066C2 |
| DERIVATIVES OF PIPERIDINE, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2298550C2 |
